{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T02:40:11Z","timestamp":1790304011333,"version":"4.1.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["31003A_176170"],"award-info":[{"award-number":["31003A_176170"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["31003A_182464"],"award-info":[{"award-number":["31003A_182464"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Microbiology"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.tim.2021.03.001","type":"journal-article","created":{"date-parts":[[2021,3,20]],"date-time":"2021-03-20T18:33:51Z","timestamp":1616265231000},"page":"973-982","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"title":["Interferon system deficiencies exacerbating severe pandemic virus infections"],"prefix":"10.1016","volume":"29","author":[{"given":"Silke","family":"Stertz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3891-9480","authenticated-orcid":false,"given":"Benjamin G.","family":"Hale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tim.2021.03.001_bb0005","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.immuni.2019.03.025","article-title":"Shared and distinct functions of type I and type III interferons","volume":"50","author":"Lazear","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.tim.2021.03.001_bb0010","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.tig.2020.08.017","article-title":"Genetic lesions of type I interferon signalling in human antiviral immunity","volume":"37","author":"Duncan","year":"2021","journal-title":"Trends Genet."},{"key":"10.1016\/j.tim.2021.03.001_bb0015","doi-asserted-by":"crossref","DOI":"10.1126\/science.abd4570","article-title":"Inborn errors of type I IFN immunity in patients with life-threatening COVID-19","volume":"370","author":"Zhang","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.tim.2021.03.001_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/jama.2020.13719","article-title":"Presence of genetic variants among young men with severe COVID-19","volume":"324","author":"van der Made","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.tim.2021.03.001_bb0025","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41586-020-03065-y","article-title":"Genetic mechanisms of critical illness in Covid-19","volume":"591","author":"Pairo-Castineira","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.tim.2021.03.001_bb0030","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1084\/jem.20181621","article-title":"Severe influenza pneumonitis in children with inherited TLR3 deficiency","volume":"216","author":"Lim","year":"2019","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.tim.2021.03.001_bb0035","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1084\/jem.20180628","article-title":"Life-threatening influenza pneumonitis in a child with inherited IRF9 deficiency","volume":"215","author":"Hernandez","year":"2018","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.tim.2021.03.001_bb0040","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1126\/science.aaa1578","article-title":"Infectious disease. Life-threatening influenza and impaired interferon amplification in human IRF7 deficiency","volume":"348","author":"Ciancanelli","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.tim.2021.03.001_bb0045","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nature10921","article-title":"IFITM3 restricts the morbidity and mortality associated with influenza","volume":"484","author":"Everitt","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.tim.2021.03.001_bb0050","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/nm.4370","article-title":"SNP-mediated disruption of CTCF binding at the IFITM3 promoter is associated with risk of severe influenza in humans","volume":"23","author":"Allen","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.tim.2021.03.001_bb0055","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1038\/ncomms2433","article-title":"Interferon-induced transmembrane protein-3 genetic variant rs12252-C is associated with severe influenza in Chinese individuals","volume":"4","author":"Zhang","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tim.2021.03.001_bb0060","doi-asserted-by":"crossref","DOI":"10.1126\/science.abd4585","article-title":"Autoantibodies against type I IFNs in patients with life-threatening COVID-19","volume":"370","author":"Bastard","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.tim.2021.03.001_bb0065","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/289496a0","article-title":"Interferon-neutralizing antibodies in a patient treated with human fibroblast interferon","volume":"289","author":"Vallbracht","year":"1981","journal-title":"Nature"},{"key":"10.1016\/j.tim.2021.03.001_bb0070","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1056\/NEJM198806023182201","article-title":"Resistance to recombinant interferon alfa-2a in hairy-cell leukemia associated with neutralizing anti-interferon antibodies","volume":"318","author":"Steis","year":"1988","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tim.2021.03.001_bb0075","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1093\/infdis\/163.4.882","article-title":"Neutralizing antibodies to interferon-alpha: relative frequency in patients treated with different interferon preparations","volume":"163","author":"Antonelli","year":"1991","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.tim.2021.03.001_bb0080","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1365-2249.1992.tb06487.x","article-title":"Serum-induced suppression of interferon (IFN) activity. Lack of evidence for the presence of specific autoantibodies to IFN-alpha in normal human sera","volume":"88","author":"Hansen","year":"1992","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.tim.2021.03.001_bb0085","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1093\/infdis\/150.5.707","article-title":"Characteristics of autoantibodies to human interferon in a patient with varicella-zoster disease","volume":"150","author":"Pozzetto","year":"1984","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.tim.2021.03.001_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4049\/jimmunol.129.1.1","article-title":"Antibodies to alpha-interferon in a patient with systemic lupus erythematosus","volume":"129","author":"Panem","year":"1982","journal-title":"J. Immunol."},{"key":"10.1016\/j.tim.2021.03.001_bb0095","doi-asserted-by":"crossref","first-page":"e289","DOI":"10.1371\/journal.pmed.0030289","article-title":"Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1","volume":"3","author":"Meager","year":"2006","journal-title":"PLoS Med."},{"key":"10.1016\/j.tim.2021.03.001_bb0100","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1172\/JCI80477","article-title":"Broad-spectrum antibodies against self-antigens and cytokines in RAG deficiency","volume":"125","author":"Walter","year":"2015","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tim.2021.03.001_bb0105","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.jaci.2013.11.038","article-title":"Autoimmunity due to RAG deficiency and estimated disease incidence in RAG1\/2 mutations","volume":"133","author":"Chen","year":"2014","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.tim.2021.03.001_bb0110","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1084\/jem.20091669","article-title":"Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines","volume":"207","author":"Kisand","year":"2010","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.tim.2021.03.001_bb0115","article-title":"Diverse functional autoantibodies in patients with COVID-19","author":"Wang","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.tim.2021.03.001_bb0120","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/s41586-021-03234-7","article-title":"Global absence and targeting of protective immune states in severe COVID-19","volume":"591","author":"Combes","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.tim.2021.03.001_bb0125","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/d41586-020-03070-1","article-title":"Interferon deficiency can lead to severe COVID","volume":"587","author":"Meffre","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.tim.2021.03.001_bb0130","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abd3876","article-title":"Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19","volume":"12","author":"Zuo","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.tim.2021.03.001_bb0135","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.cell.2020.09.016","article-title":"The immunology of multisystem inflammatory syndrome in children with COVID-19","volume":"183","author":"Consiglio","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.tim.2021.03.001_bb0140","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.cell.2020.09.034","article-title":"Mapping systemic inflammation and antibody responses in multisystem inflammatory syndrome in children (MIS-C)","volume":"183","author":"Gruber","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.tim.2021.03.001_bb0145","article-title":"New-onset IgG autoantibodies in hospitalized patients with COVID-19","author":"Chang","year":"2021","journal-title":"medRxiv"},{"key":"10.1016\/j.tim.2021.03.001_bb0150","article-title":"Broadly-targeted autoreactivity is common in severe SARS-CoV-2 infection","author":"Woodruff","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.tim.2021.03.001_bb0155","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.cell.2020.09.038","article-title":"Antigen-specific adaptive immunity to SARS-CoV-2 in acute COVID-19 and associations with age and disease severity","volume":"183","author":"Rydyznski Moderbacher","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.tim.2021.03.001_bb0160","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/s41586-020-2700-3","article-title":"Sex differences in immune responses that underlie COVID-19 disease outcomes","volume":"588","author":"Takahashi","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.tim.2021.03.001_bb0165","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.cell.2016.06.024","article-title":"AIRE-deficient patients harbor unique high-affinity disease-ameliorating autoantibodies","volume":"166","author":"Meyer","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.tim.2021.03.001_bb0170","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1365-2249.1991.tb05686.x","article-title":"Naturally occurring anti-interferon-alpha 2a antibodies in patients with acute viral hepatitis","volume":"85","author":"Ikeda","year":"1991","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.tim.2021.03.001_bb0175","doi-asserted-by":"crossref","first-page":"685","DOI":"10.4049\/jimmunol.144.2.685","article-title":"Natural antibodies to IFN-gamma in man and their increase during viral infection","volume":"144","author":"Caruso","year":"1990","journal-title":"J. Immunol."},{"key":"10.1016\/j.tim.2021.03.001_bb0180","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1172\/JCI117881","article-title":"High avidity IFN-neutralizing antibodies in pharmaceutically prepared human IgG","volume":"95","author":"Ross","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tim.2021.03.001_bb0185","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.immuni.2018.08.015","article-title":"Distinct effector B cells induced by unregulated Toll-like receptor 7 contribute to pathogenic responses in systemic lupus erythematosus","volume":"49","author":"Jenks","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.tim.2021.03.001_bb0190","doi-asserted-by":"crossref","first-page":"13759","DOI":"10.1128\/JVI.02166-14","article-title":"Molecular mimicry between dengue virus and coagulation factors induces antibodies to inhibit thrombin activity and enhance fibrinolysis","volume":"88","author":"Chuang","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.tim.2021.03.001_bb0195","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nrendo.2016.30","article-title":"Viral infections in type 1 diabetes mellitus \u2013why the beta cells?","volume":"12","author":"Op de Beeck","year":"2016","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.tim.2021.03.001_bb0200","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1084\/jem.20161596","article-title":"Type I interferon-mediated monogenic autoinflammation: The type I interferonopathies, a conceptual overview","volume":"213","author":"Rodero","year":"2016","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.tim.2021.03.001_bb0205","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.606874","article-title":"Context is key: delineating the unique functions of IFNalpha and IFNbeta in disease","volume":"11","author":"Fox","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tim.2021.03.001_bb0210","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01928-20","article-title":"Antiviral activity of type I, II, and III interferons counterbalances ACE2 inducibility and restricts SARS-CoV-2","volume":"11","author":"Busnadiego","year":"2020","journal-title":"mBio"},{"key":"10.1016\/j.tim.2021.03.001_bb0215","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.608645","article-title":"Importance of type I and III Interferons at respiratory and intestinal barrier surfaces","volume":"11","author":"Stanifer","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tim.2021.03.001_bb0220","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.immuni.2012.01.011","article-title":"Constitutive type I interferon modulates homeostatic balance through tonic signaling","volume":"36","author":"Gough","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.tim.2021.03.001_bb0225","doi-asserted-by":"crossref","DOI":"10.1007\/s11739-021-02632-z","article-title":"Electrolyte imbalance in COVID-19 patients admitted to the Emergency Department: a case\u2013control study","author":"De Carvalho","year":"2021","journal-title":"Intern. Emerg. Med."},{"key":"10.1016\/j.tim.2021.03.001_bb0230","first-page":"1","article-title":"Plasma exchange to rescue patients with autoantibodies against type I interferons and life-threatening COVID-19 pneumonia","volume":"2021","author":"de Prost","year":"2021","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.tim.2021.03.001_bb0235","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s10875-020-00933-0","article-title":"IFN-alpha2a therapy in two patients with inborn errors of TLR3 and IRF3 infected with SARS-CoV-2","volume":"41","author":"Levy","year":"2021","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.tim.2021.03.001_bb0240","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.cell.2009.12.017","article-title":"The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus","volume":"139","author":"Brass","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.tim.2021.03.001_bb0245","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1001258","article-title":"Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virus","volume":"7","author":"Huang","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.tim.2021.03.001_bb0250","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002337","article-title":"IFITM3 inhibits influenza A virus infection by preventing cytosolic entry","volume":"7","author":"Feeley","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.tim.2021.03.001_bb0255","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004048","article-title":"IFITM3 restricts influenza A virus entry by blocking the formation of fusion pores following virus\u2013endosome hemifusion","volume":"10","author":"Desai","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.tim.2021.03.001_bb0260","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2020106501","article-title":"Opposing activities of IFITM proteins in SARS-CoV-2 infection","volume":"40","author":"Shi","year":"2021","journal-title":"EMBO J."},{"key":"10.1016\/j.tim.2021.03.001_bb0265","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006610","article-title":"Interference with the production of infectious viral particles and bimodal inhibition of replication are broadly conserved antiviral properties of IFITMs","volume":"13","author":"Tartour","year":"2017","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.tim.2021.03.001_bb0270","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s12977-014-0103-y","article-title":"IFITM proteins are incorporated onto HIV-1 virion particles and negatively imprint their infectivity","volume":"11","author":"Tartour","year":"2014","journal-title":"Retrovirology"},{"key":"10.1016\/j.tim.2021.03.001_bb0275","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.chom.2014.11.001","article-title":"IFITM proteins incorporated into HIV-1 virions impair viral fusion and spread","volume":"16","author":"Compton","year":"2014","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.tim.2021.03.001_bb0280","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1073\/pnas.1321748111","article-title":"Early hypercytokinemia is associated with interferon-induced transmembrane protein-3 dysfunction and predictive of fatal H7N9 infection","volume":"111","author":"Wang","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tim.2021.03.001_bb0285","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/infdis\/jix242","article-title":"Evaluation of IFITM3 rs12252 association with severe pediatric influenza infection","volume":"216","author":"Randolph","year":"2017","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.tim.2021.03.001_bb0290","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1093\/infdis\/jiaa224","article-title":"Interferon-induced transmembrane protein 3 genetic variant rs12252-C associated with disease severity in coronavirus disease 2019","volume":"222","author":"Zhang","year":"2020","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.tim.2021.03.001_bb0295","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3390\/genes12010042","article-title":"Strong correlation between the case fatality rate of COVID-19 and the rs6598045 single nucleotide polymorphism (SNP) of the interferon-induced transmembrane protein 3 (IFITM3) gene at the population-level","volume":"12","author":"Kim","year":"2020","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.tim.2021.03.001_bb0300","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-75848-2","article-title":"Explaining among-country variation in COVID-19 case fatality rate","volume":"10","author":"Sorci","year":"2020","journal-title":"Sci. Rep."}],"container-title":["Trends in Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966842X21000603?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966842X21000603?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T18:45:18Z","timestamp":1760813118000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0966842X21000603"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":60,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S0966842X21000603"],"URL":"https:\/\/doi.org\/10.1016\/j.tim.2021.03.001","relation":{},"ISSN":["0966-842X"],"issn-type":[{"value":"0966-842X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interferon system deficiencies exacerbating severe pandemic virus infections","name":"articletitle","label":"Article Title"},{"value":"Trends in Microbiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tim.2021.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}